Titlebook: New Directions in Cancer Treatment; Ian Magrath Book 1989 Springer-Verlag Berlin Heidelberg 1989 Tumor.brain.breast cancer.cancer.cancer t

吞噬

原告

Radiotherapy Treatment Planning: Past, Present, and Futurecomputers, advanced graphics techniques, and new calculational algorithms, treatment planning is ready to progress to new levels of sophistication. This chapter will summarize the progress made in clinical treatment planning and highlight where the field may be heading over the next decade.

Exploit

新陈代谢

草本植物

过渡时期

Allogeneic Marrow Transplantation for Malignancy—Current Problems and Prospects for Improvementmarrow transplantation in the treatment of malignant disease and the major problems which limit the effectiveness of this procedure are reviewed. Major emphasis will be given to ways in which these problems are being addressed or might be addressed in the future.

砍伐

Regional Therapiesd we will review here the results of clinical trials for the main methods of regional drug administration: intra-arterial (IA), intraperitoneal (IP), intrathecal (IT), and intravesical. We will also briefly discuss the local approach to third-space accumulations.

AIL

Multidrug Resistance in Tissue Culture and Human Tissuesn said of many tumors we now consider curable. For this reason, the search for new agents must continue. But can we overcome drug resistance and make existing ineffective therapy successful? In the laboratory, this has already been accomplished; whether this can be achieved in a clinical setting is just beginning to be tested.

consent

合群

The Potential Value of Radiolabelled Monoclonal Antibodies in Cancer Therapy Not only are monoclonal antibodies highly specific, but they can be produced on a commercial scale by mass culture techniques using the hybridoma cells from which they are derived, and they can be readily purified.